Overview

Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With Vandetanib

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This is a study in healthy volunteers to assess the pharmacokinetics (PK) of Digoxin administered alone and in combination with Vandetanib.
Phase:
Phase 1
Details
Lead Sponsor:
Sanofi
Treatments:
Digoxin